MSB 3.59% $3.17 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-163

  1. 1,618 Posts.
    lightbulb Created with Sketch. 1696
    I would say 99.9% certainty it was Incyte. If you read the petition, he's arguing Jakafi from one end to the other. I would be shocked if it was anyone by Incyte barracking that hard for keeping the status quo (though maybe it's somebody who hates sick kids and wants to see them suffer more?).
    Last edited by dplane: 28/07/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$3.17
Change
0.110(3.59%)
Mkt cap ! $4.027B
Open High Low Value Volume
$3.12 $3.17 $2.98 $20.56M 6.605M

Buyers (Bids)

No. Vol. Price($)
1 300 $3.16
 

Sellers (Offers)

Price($) Vol. No.
$3.17 60964 11
View Market Depth
Last trade - 16.10pm 31/01/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.